Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Evidence and Clinical Relevance of Tumor Flare in Patients Who Discontinue Tyrosine Kinase Inhibitors for Treatment of Metastatic Renal Cell CarcinomaEur Urol 2015 Jul 01;68(1)154-160, R Iacovelli, F Massari, L Albiges, Y Loriot, C Massard, K Fizazi, B Escudier
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Renal Cell Carcinoma Center of Excellence
Visit our Renal Cell Carcinoma Center of Excellence for additional, in-depth coverage.